NasdaqGM - Nasdaq Real Time Price USD
Phibro Animal Health Corporation (PAHC)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 5:49 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
1,017,679.00
1,017,679.00
977,889.00
942,261.00
833,350.00
Cost of Revenue
704,587.00
704,587.00
679,652.00
656,861.00
561,973.00
Gross Profit
313,092.00
313,092.00
298,237.00
285,400.00
271,377.00
Operating Expense
259,777.00
259,777.00
226,390.00
206,414.00
196,509.00
Operating Income
53,315.00
53,315.00
71,847.00
78,986.00
74,868.00
Net Non Operating Interest Income Expense
-18,536.00
-18,536.00
-15,321.00
-11,875.00
-12,880.00
Other Income Expense
-23,863.00
-23,863.00
-2,455.00
5,216.00
4,480.00
Pretax Income
10,916.00
10,916.00
54,071.00
72,327.00
66,468.00
Tax Provision
8,500.00
8,500.00
21,465.00
23,152.00
12,083.00
Net Income Common Stockholders
2,416.00
2,416.00
32,606.00
49,175.00
54,385.00
Diluted NI Available to Com Stockholders
2,416.00
2,416.00
32,606.00
49,175.00
54,385.00
Basic EPS
0.33
0.06
0.81
1.21
1.34
Diluted EPS
0.33
0.06
0.81
1.21
1.34
Basic Average Shares
40,504.00
40,504.00
40,504.00
40,504.00
40,500.00
Diluted Average Shares
40,507.75
40,523.00
40,504.00
40,504.00
40,500.00
Total Operating Income as Reported
53,315.00
53,315.00
71,847.00
78,986.00
74,868.00
Total Expenses
964,364.00
964,364.00
906,042.00
863,275.00
758,482.00
Net Income from Continuing & Discontinued Operation
2,416.00
2,416.00
32,606.00
49,175.00
54,385.00
Normalized Income
21,267.77
21,267.77
34,086.37
45,628.12
50,720.36
Interest Income
4,474.00
4,474.00
3,355.00
816.00
838.00
Interest Expense
21,970.00
21,970.00
17,949.00
12,101.00
11,865.00
Net Interest Income
-18,536.00
-18,536.00
-15,321.00
-11,875.00
-12,880.00
EBIT
32,886.00
32,886.00
72,020.00
84,428.00
78,333.00
EBITDA
69,064.00
69,064.00
106,032.00
117,133.00
110,213.00
Reconciled Cost of Revenue
704,587.00
704,587.00
679,652.00
656,861.00
561,973.00
Reconciled Depreciation
36,178.00
36,178.00
34,012.00
32,705.00
31,880.00
Net Income from Continuing Operation Net Minority Interest
2,416.00
2,416.00
32,606.00
49,175.00
54,385.00
Total Unusual Items Excluding Goodwill
-23,863.00
-23,863.00
-2,455.00
5,216.00
4,480.00
Total Unusual Items
-23,863.00
-23,863.00
-2,455.00
5,216.00
4,480.00
Normalized EBITDA
92,927.00
92,927.00
108,487.00
111,917.00
105,733.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-5,011.23
-5,011.23
-974.64
1,669.12
815.36
6/30/2021 - 4/11/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CTLT Catalent, Inc.
60.18
-0.18%
PETQ PetIQ, Inc.
30.97
+0.13%
ELAN Elanco Animal Health Incorporated
12.62
-2.70%
INDV Indivior PLC
8.27
-3.39%
COLL Collegium Pharmaceutical, Inc.
36.46
-5.15%
KNSA Kiniksa Pharmaceuticals International, plc
25.89
-1.43%
ZTS Zoetis Inc.
189.45
-1.98%
SNOA Sonoma Pharmaceuticals, Inc.
2.9700
-6.01%
ORGO Organogenesis Holdings Inc.
3.1100
-1.58%
LEEEF Leef Brands Inc.
0.0190
+2.70%